At €1.39, Is It Time To Put Servizi Italia S.p.A. (BIT:SRI) On Your Watch List?
Jan 28
Italian (Borsa Italiana) Healthcare Sector Analysis
UpdatedJan 30, 2023
DataAggregated Company Financials
Companies18
- 7D-0.8%
- 3M2.2%
- 1Y-17.2%
- YTD-0.4%
Over the last 7 days, the Healthcare industry has remained flat, although notably Philogen gained 4.9%. Unfortunately though, the industry is down 17% over the past 12 months. Looking forward, earnings are forecast to grow by 12% annually.
Sector Valuation and Performance
Has the Italian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 30 Jan 2023 | €23.7b | €7.4b | €886.1m | 23.3x | 26.8x | 3.2x |
| Wed, 28 Dec 2022 | €23.4b | €7.4b | €886.1m | 22.1x | 26.5x | 3.2x |
| Fri, 25 Nov 2022 | €24.3b | €7.4b | €886.1m | 22.8x | 27.5x | 3.3x |
| Sun, 23 Oct 2022 | €22.6b | €7.3b | €908.8m | 18.8x | 24.8x | 3.1x |
| Tue, 20 Sep 2022 | €23.0b | €7.2b | €897.0m | 21.2x | 25.7x | 3.2x |
| Thu, 18 Aug 2022 | €25.2b | €7.2b | €887.4m | 23.8x | 28.4x | 3.5x |
| Sat, 16 Jul 2022 | €25.4b | €6.9b | €957.4m | 22.3x | 26.6x | 3.7x |
| Mon, 13 Jun 2022 | €23.1b | €6.9b | €957.4m | 19.7x | 24.1x | 3.4x |
| Wed, 11 May 2022 | €25.7b | €6.9b | €960.7m | 21.5x | 26.8x | 3.7x |
| Fri, 08 Apr 2022 | €30.8b | €6.7b | €949.7m | 24.2x | 32.5x | 4.6x |
| Sun, 06 Mar 2022 | €28.3b | €6.8b | €1.0b | 19.9x | 27.4x | 4.1x |
| Tue, 01 Feb 2022 | €31.7b | €6.8b | €1.0b | 22.2x | 30.9x | 4.6x |
| Thu, 30 Dec 2021 | €37.3b | €6.8b | €1.0b | 24.7x | 36.4x | 5.5x |
| Sat, 27 Nov 2021 | €36.9b | €6.8b | €1.0b | 23.5x | 36x | 5.4x |
| Mon, 25 Oct 2021 | €37.1b | €6.6b | €1.0b | 27.6x | 36.6x | 5.6x |
| Wed, 22 Sep 2021 | €37.9b | €6.6b | €1.0b | 27.1x | 37.3x | 5.7x |
| Fri, 20 Aug 2021 | €38.3b | €6.4b | €1.0b | 31.2x | 37.6x | 5.9x |
| Fri, 04 Jun 2021 | €31.9b | €6.1b | €925.0m | 26.1x | 34.5x | 5.3x |
| Mon, 08 Mar 2021 | €30.1b | €5.8b | €866.3m | 25.7x | 34.7x | 5.1x |
| Thu, 10 Dec 2020 | €30.7b | €5.7b | €815.4m | 34.1x | 37.7x | 5.4x |
| Wed, 02 Sep 2020 | €27.8b | €5.5b | €754.5m | 33.2x | 36.9x | 5x |
| Sat, 06 Jun 2020 | €26.4b | €5.5b | €736.0m | 27x | 35.8x | 4.8x |
| Tue, 10 Mar 2020 | €21.3b | €5.5b | €738.1m | 26.1x | 28.9x | 3.9x |
Price to Earnings Ratio
29.7x
Current Industry PE
- Investors are pessimistic on the Italian Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 26.8x which is lower than its 3-year average PE of 32.2x.
- The 3-year average PS ratio of 4.6x is higher than the industry's current PS ratio of 3.2x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 6.3% per year over the last three years.
- Revenues for these companies have grown 11% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Italian Healthcare sector?
| IT Market | 1.13% | |
| Healthcare | -0.79% | |
| Biotech | 6.01% | |
| Life Sciences | 0.24% | |
| Healthcare Services | 0.21% | |
| Healthtech | -0.55% | |
| Medical Equipment | -0.67% | |
| Pharma | -2.01% | |
Industry PE
- Investors are most optimistic about the Healthtech industry which is trading above its 3-year average PE ratio of 30.5x.
- Analysts are expecting annual earnings growth of 35.9%, which is higher than its past year's earnings decline of 4.0% per year.
Forecasted Growth
- Analysts are most optimistic on the Life Sciences industry, expecting annual earnings growth of 109% over the next 5 years.
- In contrast, the Medical Equipment industry is expected to see its earnings grow by 7.4% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| PHIL Philogen | €14.98 | 4.9% +€20.4m | 4.6% | PS18.8x | |
| SRI Servizi Italia | €1.39 | 9.1% +€3.4m | -30.9% | PE8.5x | |
| ABS Arterra Bioscience | €2.59 | 9.3% +€1.5m | -8.8% | PE12.3x | |
| SVS Svas Biosana | €9.75 | 2.5% +€1.3m | -27.5% | PE18.7x | |
| PRL Pierrel | €0.18 | 2.1% +€869.7k | -16.1% | PE37.3x |
